Associate Director, Oncology Lifecycle Management - Hematologic Oncology

Associate Director, Oncology Lifecycle Management - Hematologic Oncology US Remote Position Summary Natera is a global leader in cell‑free DNA testing focused on disease management in reproductive health, oncology, and organ transplantation. Signatera is a personalized tumor‑informed test for molecular residual disease assessment and surveillance monitoring in patients previously diagnosed with cancer. Signatera is covered by Medicare for colorectal cancer, muscle‑invasive bladder cancer, high‑risk breast cancer, ovarian cancer, lung cancer, and immunotherapy response monitoring for any solid tumor. As Associate Director of Oncology Lifecycle Management for Hematologic Malignancies you will work in a highly matrixed environment to shape strategic direction and drive execution for company success in Hematologic Oncology. Primary Responsibilities Own lifecycle planning and product launch for a diagnostic portfolio in Hematologic Malignancies (Lymphoma, Multiple Myeloma, Chronic Lymphocytic Leukemia), collaborating with cross‑functional teams to develop and execute a strategic plan that drives usage, awareness, and advocacy across key stakeholders worldwide. Lead a MM/CLL Lifecycle Team accountable for progress on tumor goals and deploying resources to maximize outcomes. Establish tumor‑specific goals for the lifecycle team and across functions. Serve as a critical member of clinical/medical teams, defining and prioritizing key indications and addressing evidence gaps. Serve as a critical member on commercial subteams, escalating and addressing barriers to commercial adoption. Maintain deep expertise in the hematology oncology space by integrating real‑time customer insights, publications, data presentations, competitive and market intelligence. Drive market access efforts, leading the development of reimbursement dossiers for Medicare/MolDx and commercial payers to secure coverage for non‑covered indications. Develop and execute KOL engagement strategies, collaborating with marketing and medical teams to gather insights, build relationships, and foster advocacy. Shape the value proposition for Natera’s oncology products in collaboration with Medical Affairs and Commercial Marketing, leveraging clinical evidence and market dynamics. Co‑lead advisory boards and market research efforts in partnership with Medical Affairs. Regularly present strategic plans and progress to executive leadership. Qualifications Bachelor’s degree with 5+ years of relevant experience; advanced degree preferred (MBA or PhD). Hematologic oncology experience strongly preferred. 5+ years experience in product marketing, market analytics at a pharmaceutical/biotech company. Working knowledge of oncology molecular testing/biomarkers. ~25% travel required (advisory boards, congresses, sales/marketing meetings, customer meetings). Knowledge, Skills & Abilities Ability to lead without authority, influence and inspire individuals. Proven strategic agility with an enterprise mindset and executive presence. Ability to partner and collaborate across a broad range of internal and external partners. Strong customer orientation and focus, particularly establishing thought‑leader relationships. Proven ability to communicate complex concepts simply (biomarkers, multiple indications, etc.). Strong organizational/time‑management skills; manage and complete multiple projects. Compensation & Total Rewards Base pay: $133,600 – $167,000 USD. Additional compensation and benefits through Natera’s Total Rewards program, including: Annual performance incentive bonus, long‑term equity awards, 401(k) with company match, generous paid time off and company holidays, additional wellness and work‑life benefits. EEO Statement All qualified applicants are encouraged to apply and will be considered without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, age, veteran status, disability or any other legally protected status. We also consider qualified applicants regardless of criminal histories, consistent with applicable laws. #J-18808-Ljbffr